HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of recurrent duodenal carcinoma successfully controlled with FOLFOX treatment].

Abstract
A 60-year-old woman was diagnosed as having duodenal cancer by upper gastrointestinal endoscopy and biopsy. Pylorus-preserving pancreatoduodenectomy was performed. Pathological findings suggested T4(CBD)N1M0 primary duodenal carcinoma. Adjuvant chemotherapy with S-1(80 mg/m² of S-1 administered for 2 weeks followed by a 1-week drug-free period)was administered after surgery. One year after the surgery, computed tomography(CT)scans showed swelling of the paraaortic lymph nodes. Recurrence of the duodenal carcinoma was diagnosed, and gemcitabine chemotherapy was initiated. Eight months later, CT scans revealed lung metastasis. The patient was then treated with oxaliplatin in combination with infusional 5-fluorouracil/Leucovorin(FOLFOX regimen). After completing 6 courses of the chemotherapy regimen, CT scans showed a partial response(PR). Currently, at 1 year, PR has been maintained. Therefore, we suggest that the FOLFOX regimen can be highly effective for the treatment of patients with duodenal carcinoma.
AuthorsToshiaki Yasui, Hideyo Mukubo, Shinichi Nakanuma, Nariatsu Sato, Ichiro Kita
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 40 Issue 12 Pg. 1726-8 (Nov 2013) ISSN: 0385-0684 [Print] Japan
PMID24393902 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Organoplatinum Compounds
  • Leucovorin
  • Fluorouracil
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Duodenal Neoplasms (drug therapy, pathology, surgery)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Leucovorin (administration & dosage)
  • Lung Neoplasms (drug therapy, secondary)
  • Lymphatic Metastasis
  • Middle Aged
  • Organoplatinum Compounds (administration & dosage)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: